Foothill Ventures — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers.
BiotechDeep TechHardwareHealthtechPleasanton, US
Serge Saxonov(Founder)inBen Hindson(Founder)inBrad Crutchfield(Chief Commercial Officer)Jean Philibert(Chief People Officer)Eric S Whitaker(General Counsel)inJustin McAnear(Chief Financial Officer)
Co-investorsForesite CapitalKhosla VenturesOMX VenturesPaladin Capital GroupSoftBank Vision FundVenrock+4 more
Emmanuel Straschnov(Founder)inJosh Haas(Founder)in
Co-investorsDig Ventures Management LimitedKima VenturesNewView CapitalSignalFire
Celero Systems is developing an ingestible pill-based platform that monitors cardiac and respiratory vital signs and delivers medication, aiming to monitor, diagnose, and treat life-threatening conditions without wearables or wires.
Deep TechDigital HealthMedical DevicesBrookline, US
Xin Huang(Director)Benjamin Pless(Executive Officer, Director)Carlo Giovanni Traverso(Director)Allan May(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.